STAAHL BRETT enters SCRIBE THERAPEUTICS, INC. with 524.34K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/24/2026ACC: 0002147277-26-000001
524.34K
Baseline shares
100% direct
524.34K
Direct ownership
1 position
26.70K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned524.34K
Total
524.34K direct524.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 524.34K | Direct |
| Total | 524.34K | 524.34K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
2.46K
Shares owned
N/A
Exercise price
3.08
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
1.69K
Shares owned
N/A
Exercise price
6.40
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
4.75K
Shares owned
N/A
Exercise price
19.13
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
17.80K
Shares owned
N/A
Exercise price
6.40
Expiration
—
Exercise window
—
Total
Underlying
26.70K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 3.08 | — | — | 2.46K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.40 | — | — | 1.69K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 19.13 | — | — | 4.75K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.40 | — | — | 17.80K | N/A |
| Total | 26.70K | 0.00 | ||||